Press release
Cushing's Disease Market is Valued at USD 686.89 Million at a CAGR of 9.44% During the Forecast Period 2029
Data Bridge Market Research analyses that the Cushing's disease market was valued at USD 333.80 million in 2021 and is expected to reach USD 686.89 million by 2029, registering a CAGR of 9.44% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
In recent years, the Cushing's disease market is anticipated to grow rapidly during the forecast period. Cushing's syndrome is a group of symptoms brought on by a high hormone cortisol level. The syndrome, also known as hypercortisolism, is frequently induced by corticosteroid medication adverse effects. Inflammation and autoimmune diseases are commonly treated with corticosteroids. Iatrogenic Cushing's syndrome and endogenous Cushing's syndrome are the two kinds of Cushing's syndrome. Weight gain, adipose tissue deposits around the abdomen and back, purple stretch marks, thinner skin that is easily bruised, acne, and other symptoms are common.
High blood pressure, reddish stretch marks, abdominal obesity, round red face, weak muscles, weak bones, a fat mass between the shoulders, and delicate skin that heals slowly are all symptoms and indicators of Cushing's syndrome. Cushing's syndrome is caused by two main factors: excessive cortisol-like medicines like prednisone, and tumours formed by adrenal glands overproducing cortisol. Other tumors, such as those linked to hereditary illnesses including multiple endocrine neoplasia type 1 and Carney complex, may potentially be responsible for this condition. In most situations, a combination of surgery, radiation, and chemotherapy can be used to treat and cure the condition.
Download the Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cushings-disease-market
Global Cushing's Disease Market Scope
The Cushing's disease market is segmented on the basis of treatment type, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment Type
Surgery
Radiation Therapy
Drugs
Ke-toconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide
Others
Diagnosis
Petrosal Sinus Sampling
Saliva Test
Urine and Blood Tests
Imaging Tests
Computerized tomography (CT) scans
Magnetic resonance imaging (MRI)
Others
Route of Administration
Oral
Parenteral
Others
End-Users
Hospitals
Specialty Clinics
Homecare
Others
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Competitive Landscape and Cushing's Disease Market Share Analysis
The Cushing's disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Cushing's disease market.
Some of the major players operating in the Cushing's disease market are:
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd.(Israel)
Sanofi (France)
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
Zydus Cadila (India)
AstraZeneca (UK)
Johnson & Johnson (US)
Bayer AG (Germany)
Sun Pharmaceutical Industries Ltd. (India)
Bristol-Myers Squibb Company (US)
Eli Lilly and Company (US)
Strides Pharma Science Limited (India)
Cipla Inc. (US)
LEO Pharma A/S (Denmark)
Aurobindo Pharma (India)
Lupin (India)
Hikma Pharmaceuticals PLC (UK)
Top Trendings Reports:-
https://dbmr006.blogspot.com/2023/06/medical-oxygen-concentrators-and-oxygen_27.html
https://dbmr006.blogspot.com/2023/06/mens-health-market-is-set-to-rise_27.html
https://dbmr006.blogspot.com/2023/06/myocarditis-disease-market-is-estimated_27.html
https://dbmr006.blogspot.com/2023/06/post-acute-myocardial-infarction-market_27.html
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on
Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cushing's Disease Market is Valued at USD 686.89 Million at a CAGR of 9.44% During the Forecast Period 2029 here
News-ID: 3104574 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Cushing
Cushing Syndrome Market Trends is Electrifying Growth Cycle: Bristol Myers Squib …
The latest study released on the Global Cushing Syndrome Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W …
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Cushing Syndrome…
Cushing Syndrome Market Is Booming So Rapidly | Recordati, Diurnal Group, Pfizer
The Global Cushing Syndrome Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 22.6% to reach $8.8 Billion by 2034.
The latest study released on the Global Cushing Syndrome Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for…
The Cushing’s Disease Treatment Market to grow at an invigorating pace in the …
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
Somatostatin Analogs Market Report 2018: Segmentation by Product (Octreotide, La …
Global Somatostatin Analogs market research report provides company profile for Chiasma, Ipsen Biopharmaceutical, Novartis, Peptron and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the basis of…
Cushing’s Disease Treatment Market Forecast over 2017 – 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease…
